News

  • NCPC’s omitevirumab injection was approved

    NCPC’s omitevirumab injection was approved for marketing   North China Pharmaceuticals officially obtained the drug registration certificate of omitevirumab injection (Xunke®) issued by the State Drug Administration, marking the official approval of omitevirumab injection for marketing...
    Lestu meira
  • Sales Representative

    Join NCPCVET and be part of a legacy where your growth is just as important as ours. We are passionate about and committed to providing customers with better and innovative solutions as well as high-quality services in a bid to help improve food safety and animal welfare. We know that when animal...
    Lestu meira
  • NCPCVET Pet Drugs Listed

    NCPCVET Pet Drugs Listed

        The pet business division of NCPC was formally established in January 2018,with the strong research and development strength and advanced equipment of human medicine in North China Pharmaceutical Group, we will strive to build famous brands at home and abroad in the field of pet medicine, we...
    Lestu meira
  • Gamithromycin vottun

    Nýlega, NCPCVET vann nýtt lyf vottun fyrir á landsvísu annars flokks nýju dýralæknis drugs- "Gamithromycin" og "Gamithromycin innspýtingu." Gamithromycin er nýstárleg hálfsamtengt makrólíð sýklalyfsins. Á þessari stundu, týlósín og tilmicosin eru víða notuð sem ma ...
    Lestu meira
WhatsApp Online Chat!